Cooper Companies (COO) Cash from Investing Activities (2009 - 2026)

Cooper Companies (COO) recorded quarterly Cash from Investing Activities of -$90.0 million in Q2 2026, up 12.54% quarter-over-quarter from -$102.9 million in Q1 2026, and down 13.64% year-on-year from -$104.2 million in Q2 2025.

Cooper Companies (COO) Cash from Investing Activities (2009 - 2026) Analysis & Trends

Cooper Companies has disclosed Cash from Investing Activities across 18 years of filings, most recently posting -$90.0 million for Q2 2026.

  • For the quarter ending Q2 2026, Cash from Investing Activities fell 13.64% year-over-year to -$90.0 million; the trailing twelve-month figure through Apr 2026 stood at -$389.8 million (up 28.04% YoY), and the FY2025 full-year result was -$372.9 million, up 51.23% from the prior year.
  • Cash from Investing Activities was -$90.0 million for Q2 2026 at Cooper Companies, up from -$102.9 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at -$15.7 million in Q2 2022 and troughed at -$1.7 billion in Q1 2022.
  • The 5-year median for Cash from Investing Activities is -$98.4 million (2025), against an average of -$200.6 million.
  • The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities sank 1130.14% in 2022, then surged 93.21% in 2023.
  • Year by year, Cash from Investing Activities stood at -$99.7 million in 2022, then sank by 61.28% to -$160.8 million in 2023, then slumped by 50.25% to -$241.6 million in 2024, then soared by 59.11% to -$98.8 million in 2025, then increased by 8.91% to -$90.0 million in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were -$90.0 million in Q2 2026, -$102.9 million in Q1 2026, and -$98.8 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn -914.50 Mn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -139.00 Mn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn -96.00 Mn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn -58.03 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn -42.70 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn -77.00 Mn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -90.00 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn -131.58 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn -133.00 Mn
10 Aptargroup 7.72 Bn 7.52 Bn 351.91 Mn -65.10 Mn

Historic Data

Download Data
DateValue
Apr 30, 2026 -90.00 Mn
Apr 30, 2026 -90.00 Mn
Jan 31, 2026 -102.90 Mn
Jan 31, 2026 -102.90 Mn
Oct 31, 2025 -98.80 Mn
Oct 31, 2025 -98.80 Mn
Jul 31, 2025 -98.10 Mn
Jul 31, 2025 -98.10 Mn
Apr 30, 2025 -79.20 Mn
Apr 30, 2025 -79.20 Mn
Jan 31, 2025 -96.80 Mn
Jan 31, 2025 -96.80 Mn
Oct 31, 2024 -241.60 Mn
Oct 31, 2024 -241.60 Mn
Jul 31, 2024 -124.10 Mn
Jul 31, 2024 -124.10 Mn
Apr 30, 2024 -74.80 Mn
Apr 30, 2024 -74.80 Mn
Jan 31, 2024 -324.10 Mn
Jan 31, 2024 -324.10 Mn